Central Asia vs Niue: Proportion of the target population who received
Central Asia
97.0%
in 2024
Niue
99.0%
in 2024
Central Asia rank
1st
Niue rank
1st
Proportion of the target population who received over time
- Central Asia
- Niue
How they compare
Niue currently reports 99.0% against 97.0% in Central Asia, a difference of 2.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Niue ahead.
Central Asia ranks 1st and Niue ranks 1st of 31 groups.
Niue has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central Asia | Niue | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 84.3% | 93.9% | 9.6% | Niue |
| 2010s | 96.5% | 98.8% | 2.3% | Niue |
| 2020s | 97.4% | 99.0% | 1.6% | Niue |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Central Asia or Niue?
- Niue, at 99.0% against 97.0% in Central Asia as of 2024.
- What is the difference in proportion of the target population who received between Central Asia and Niue?
- 2.0%, with Niue ahead.
- How many years of comparable data are there for Central Asia and Niue?
- 25 years are reported by both, from 2000 to 2024.
- How do Central Asia and Niue rank globally for proportion of the target population who received?
- Central Asia ranks 1st and Niue ranks 1st of 31 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.